West Pharmaceutical Services Inc. Discusses Q3 2013 Results (Webcast)

Oct.31.13 | About: West Pharmaceutical (WST)

West Pharm (WST): Q3 EPS of $0.39 beats by $0.03. Revenue of $341.8M (+12.5% Y/Y) beats by $8.5M. (PR)

The following audio is from a conference call that will begin on October 31, 2013 at 09:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion.

If you would like to view a transcript of this call, please click here.